Astrazeneca

Pasteur Institute ends main vaccine project

10:16 pm January 25, 2021

Paris : France’s Pasteur Institute announced on Monday it is abandoning its main COVID-19 vaccine project after clinical trial tests did not meet expectations. The decision was made in coordination with its industrial partner, U.S. pharmaceutical company Merck, the statement said. The project was attempting to develop a COVID-19 vaccine based on an existing measles vaccine. Pasteur’s statement stressed that […]

Read More
Delhi has less than a day’s stock of Covaxin for 45-plus age group: Atishi

Bharat Biotech set to dispatch first consignment of Covaxin

2:55 pm January 12, 2021

Hyderabad : Bharat Biotech, which has received Emergency Use Authorisation approval from the Drug Controller General of India for its COVID-19 vaccine Covaxin,is set to dispatch it from the Rajiv Gandhi International Airport here on Tuesday evening, a senior official of the Airports cargo division said. ”Today we have received the first consignment of vaccines […]

Read More

Oxford/AstraZeneca vaccine expands to General Practice services in UK

8:41 pm January 7, 2021

London : Supplies of the Oxford University vaccine produced by AstraZeneca began expanding to General Practice (GP) led services in the UK from Thursday to make it easier to protect care home residents and other vulnerable people against COVID-19, the British government said. As part of a phased rollout since the jabs received regulatory approval last month, the vaccine has been […]

Read More

All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT Secy

9:47 pm January 5, 2021

New Delhi: All Indian vaccines being developed against the coronavirus will have to be stored at 2-8 degrees Celsius as the logistics have been worked out while considering temperature as a factor, Department of Biotechnology Secretary Renu Swarup said on Tuesday. Swarup said Bharat Biotech’s COVID-19 vaccine Covaxin and Oxford AstraZeneca’s Covishield have robustly undergone immunoassay lab tests. “(For) all our […]

Read More
Delhi has less than a day’s stock of Covaxin for 45-plus age group: Atishi

Bharat Biotech, Serum Institute declare truce, pledge for smooth roll out of COVID-19 vaccines

9:23 pm January 5, 2021

Hyderabad : After their ugly public spat, Serum Institute of India and Bharat Biotech on Tuesday buried the hatchet and issued a joint statement saying they will work together to develop, manufacture and supply the COVID-19 vaccines in the country and globally. In the statement posted on their respective twitter accounts, the companies said Serum […]

Read More